Article Information
History
- March 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kasope L. Wolffs1,*,
- Bethan Mansfield1,
- Richard T. Bruce1,
- Ping Huang1,
- Martin Schepelmann1,2,
- Sarah C Brennan1,3,
- Line Verckist4,
- Dirk Adriaensen4,
- Rachel Paes De Araújo5,
- Luis A.J. Mur5,
- Richard Attanoos6,
- Keir E. Lewis7,
- Jeremy P.T. Ward8,
- Christopher J. Corrigan8,
- Paul J. Kemp1,
- Benjamin D. Hope-Gill9 and
- Daniela Riccardi1,*
- 1School of Biosciences, Cardiff University, Cardiff, United Kingdom
- 2Medical University of Vienna, Institute of Pathophysiology and Allergy Research, Vienna, Austria
- 3School of Life and Environmental Science, University of Sydney, NSW, Australia
- 4Laboratory of Cell Biology and Histology, University of Antwerp, Antwerp, Belgium
- 5Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, Ceredigion, United Kingdom
- 6Department of Cellular Pathology, University Hospital of Wales and School of Medicine, Cardiff University, Cardiff, United Kingdom
- 7School of Medicine, Swansea University, and Respiratory Innovation Wales, Swansea, United Kingdom
- 8Division of Asthma, Allergy and Lung Biology, King’s College London, London, United Kingdom
- 9Department of Respiratory Medicine, Cardiff and Vale University Health Board, Cardiff, United Kingdom
- ↵*Address correspondence to:
Daniela Riccardi, PhD, Division of Biomedicine, Cardiff University, Cardiff CF10 3AX, United Kingdom, Telephone: +44 (029) 208 79132, Email: Riccardi{at}cardiff.ac.uk, Kasope L. Wolffs, BSc, Division of Biomedicine, Cardiff University, Cardiff CF10 3AX, United Kingdom, Telephone: +44 (029) 208 79069, Email: OlukogbonKL2{at}cardiff.ac.uk
Posted March 16, 2020.
Calcium-sensing receptor antagonism as a novel therapeutic for pulmonary fibrosis
